BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,056 filers reported holding BAXTER INTL INC in Q1 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $225,000 | -14.4% | 3,418 | 0.0% | 0.03% | +3.6% |
Q3 2018 | $263,000 | -9.6% | 3,418 | -14.9% | 0.03% | -9.7% |
Q2 2018 | $291,000 | -82.4% | 4,018 | -84.2% | 0.03% | -82.6% |
Q1 2018 | $1,653,000 | -9.4% | 25,412 | -10.0% | 0.18% | -5.3% |
Q4 2017 | $1,825,000 | +1.0% | 28,234 | -2.0% | 0.19% | +1.6% |
Q3 2017 | $1,807,000 | -22.8% | 28,812 | -25.4% | 0.18% | -18.9% |
Q2 2017 | $2,340,000 | -2.7% | 38,647 | -16.7% | 0.23% | -3.4% |
Q1 2017 | $2,406,000 | +16.3% | 46,391 | -0.5% | 0.24% | +20.4% |
Q4 2016 | $2,068,000 | -16.7% | 46,641 | -10.6% | 0.20% | -15.5% |
Q3 2016 | $2,483,000 | -6.2% | 52,163 | -10.9% | 0.23% | -6.5% |
Q2 2016 | $2,648,000 | +7.3% | 58,552 | -2.6% | 0.25% | +6.0% |
Q1 2016 | $2,468,000 | -2.6% | 60,095 | -9.5% | 0.23% | +7.8% |
Q4 2015 | $2,534,000 | +16.2% | 66,415 | 0.0% | 0.22% | +13.6% |
Q3 2015 | $2,181,000 | -69.1% | 66,415 | -34.2% | 0.19% | -63.3% |
Q2 2015 | $7,058,000 | -10.1% | 100,934 | -12.0% | 0.52% | -1.3% |
Q1 2015 | $7,853,000 | -12.8% | 114,634 | -6.7% | 0.53% | -5.9% |
Q4 2014 | $9,001,000 | +1.9% | 122,808 | -0.2% | 0.56% | +3.5% |
Q3 2014 | $8,829,000 | -7.9% | 123,018 | -7.2% | 0.54% | -6.7% |
Q2 2014 | $9,589,000 | -2.6% | 132,628 | -0.9% | 0.58% | -6.1% |
Q1 2014 | $9,843,000 | +5.5% | 133,778 | -0.3% | 0.62% | +4.4% |
Q4 2013 | $9,332,000 | +7.3% | 134,178 | +1.4% | 0.59% | +1.2% |
Q3 2013 | $8,696,000 | -20.1% | 132,378 | -15.8% | 0.58% | -17.3% |
Q2 2013 | $10,884,000 | – | 157,128 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |